Advertisement

Advertisement

GNPX Stock Latest News

Genprex receives patent grant from The Israel Patent Office

The FlyGenprex receives patent grant from The Israel Patent Office

Genprex Expands Reqorsa Cancer Therapy Patent Protection in Israel

PremiumCompany Announcements

Genprex Expands Reqorsa Cancer Therapy Patent Protection in Israel

7d ago

Genprex Highlights Promising Preclinical Data for Diabetes Gene Therapy

PremiumCompany Announcements

Genprex Highlights Promising Preclinical Data for Diabetes Gene Therapy

9d ago

Genprex Expands Lung Cancer Gene Therapy Research Collaboration

PremiumCompany Announcements

Genprex Expands Lung Cancer Gene Therapy Research Collaboration

16d ago

Genprex enters research agreement with UT MD Anderson

PremiumThe Fly

Genprex enters research agreement with UT MD Anderson

16d ago

Genprex announces presentations on Reqorsa Gene Therapy at 2026 AACR

PremiumThe FlyGenprex announces presentations on Reqorsa Gene Therapy at 2026 AACR

17d ago

Genprex Highlights New Reqorsa Preclinical Data at AACR

Company Announcements

Genprex Highlights New Reqorsa Preclinical Data at AACR

2M ago

Genprex collaborators present on use of Reqorsa at AACR meeting

The Fly

Genprex collaborators present on use of Reqorsa at AACR meeting

2M ago

Genprex Secures Key Global Patents for REQORSA Therapy

PremiumCompany Announcements

Genprex Secures Key Global Patents for REQORSA Therapy

2M ago

Genprex granted Japanese and EU patents for Reqorsa Gene Therapy

PremiumThe Fly

Genprex granted Japanese and EU patents for Reqorsa Gene Therapy

2M ago

Genprex Gains Australian Patent Acceptance for REQORSA Therapy

PremiumCompany Announcements

Genprex Gains Australian Patent Acceptance for REQORSA Therapy

3M ago

Genprex’s patent application for Reqorsa Gene Therapy accepted by IP Australia

PremiumThe Fly

Genprex’s patent application for Reqorsa Gene Therapy accepted by IP Australia

3M ago

Genprex Regains Nasdaq Compliance but Faces Ongoing Monitoring

PremiumCompany AnnouncementsGenprex Regains Nasdaq Compliance but Faces Ongoing Monitoring

4M ago

Genprex advances GPX-002 diabetes gene therapy program

Company Announcements

Genprex advances GPX-002 diabetes gene therapy program

4M ago

Genprex Reports Positive Preclinical Results for GPX-002 Diabetes Therapy

Company Announcements

Genprex Reports Positive Preclinical Results for GPX-002 Diabetes Therapy

4M ago

Genprex reports ‘positive’ preclinical data from study of GPX-002

PremiumThe Fly

Genprex reports ‘positive’ preclinical data from study of GPX-002

4M ago

Genprex publishes data from Acclaim-1 Phase 1 trial of Reqorsa Gene Therapy

PremiumThe Fly

Genprex publishes data from Acclaim-1 Phase 1 trial of Reqorsa Gene Therapy

5M ago

Genprex Announces $75 Million Stock Offering

PremiumCompany Announcements

Genprex Announces $75 Million Stock Offering

6M ago

Genprex files to sell 1.28M shares of common stock for holders

PremiumThe Fly

Genprex files to sell 1.28M shares of common stock for holders

6M ago

Genprex Expands Clinical Trials with New Site Addition

PremiumCompany AnnouncementsGenprex Expands Clinical Trials with New Site Addition

6M ago

Genprex adds Gabrail Cancer Center for Acclaim clinical trials 1 and 3

The Fly

Genprex adds Gabrail Cancer Center for Acclaim clinical trials 1 and 3

6M ago

Genprex Secures U.S. Patent for Reqorsa® Therapy

Company Announcements

Genprex Secures U.S. Patent for Reqorsa® Therapy

6M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >